Planning begins by translating CT and other medical images into treatment structures: target volumes identify the areas intended for irradiation, while organs at risk mark nearby healthy tissues requiring protection. These structures become constraints for dose calculations and optimization. Their accurate delineation helps the team balance adequate tumor coverage against unnecessary exposure, directly influencing the expected treatment distribution.
Beam direction, energy, and intensity are selected together rather than independently. Computerized dose calculations estimate how these choices distribute radiation, while optimization adjusts the plan against prescribed dose constraints. The resulting balance determines whether the tumor receives the intended dose while nearby organs receive less exposure, making parameter selection central to limiting toxicity.
Three-dimensional conformal radiotherapy, intensity-modulated radiotherapy, and image-guided treatment represent different planning capabilities. The first emphasizes conforming radiation to the three-dimensional target, the second varies beam intensity, and the third uses imaging to guide treatment. Selection depends on whether the principal need is shaping dose, modulating it, or supporting image-guided delivery.
These computational steps convert the proposed beam arrangement into an estimated dose distribution and test it against prescribed constraints. Optimization can adjust the plan so intended target coverage and protection of organs at risk are considered together. This provides a quantitative basis for comparing candidate plans before the clinical team approves one for treatment.
After a plan is designed, radiation oncologists, medical physicists, and dosimetrists review it as a multidisciplinary team. Quality assurance is performed before treatment begins to check that the planned delivery is suitable for clinical use. This review stage adds professional oversight to the calculated dose distribution and helps prevent an unverified plan from reaching treatment.
Planning is particularly relevant when clinicians must deliver radiation to a tumor near sensitive healthy tissue. In that setting, three-dimensional conformal radiotherapy, intensity-modulated radiotherapy, and image-guided treatment provide planning pathways that can support tumor control while reducing treatment-related toxicity. The plan also gives the care team a structured basis for selecting and reviewing the delivery approach.